577 related articles for article (PubMed ID: 28417311)
1. Immune Checkpoint Inhibitors for Brain Metastases.
Tan AC; Heimberger AB; Menzies AM; Pavlakis N; Khasraw M
Curr Oncol Rep; 2017 Jun; 19(6):38. PubMed ID: 28417311
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Inhibitors in Brain Metastases: From Biology to Treatment.
Berghoff AS; Venur VA; Preusser M; Ahluwalia MS
Am Soc Clin Oncol Educ Book; 2016; 35():e116-22. PubMed ID: 27249713
[TBL] [Abstract][Full Text] [Related]
3. Systemic therapies for melanoma brain metastases: which drug for whom and when?
Ramanujam S; Schadendorf D; Long GV
Chin Clin Oncol; 2015 Jun; 4(2):25. PubMed ID: 26112811
[TBL] [Abstract][Full Text] [Related]
4. The role of systemic therapies in the management of melanoma brain metastases.
Lyle M; Long GV
Curr Opin Oncol; 2014 Mar; 26(2):222-9. PubMed ID: 24434634
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint blockade in patients with melanoma metastatic to the brain.
Di Giacomo AM; Margolin K
Semin Oncol; 2015 Jun; 42(3):459-65. PubMed ID: 25965364
[TBL] [Abstract][Full Text] [Related]
6. The biology and therapeutic management of melanoma brain metastases.
Abate-Daga D; Ramello MC; Smalley I; Forsyth PA; Smalley KSM
Biochem Pharmacol; 2018 Jul; 153():35-45. PubMed ID: 29278675
[TBL] [Abstract][Full Text] [Related]
7. Management of Brain Metastases in the New Era of Checkpoint Inhibition.
Lauko A; Thapa B; Venur VA; Ahluwalia MS
Curr Neurol Neurosci Rep; 2018 Aug; 18(10):70. PubMed ID: 30121715
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases.
Lehrer EJ; McGee HM; Peterson JL; Vallow L; Ruiz-Garcia H; Zaorsky NG; Sharma S; Trifiletti DM
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301252
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M
Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962
[TBL] [Abstract][Full Text] [Related]
10. Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review.
Spagnolo F; Picasso V; Lambertini M; Ottaviano V; Dozin B; Queirolo P
Cancer Treat Rev; 2016 Apr; 45():38-45. PubMed ID: 26975020
[TBL] [Abstract][Full Text] [Related]
11. Treatment of melanoma brain metastases.
Goldinger SM; Panje C; Nathan P
Curr Opin Oncol; 2016 Mar; 28(2):159-65. PubMed ID: 26809015
[TBL] [Abstract][Full Text] [Related]
12. Melanoma-induced brain metastases.
McWilliams RR; Rao RD; Buckner JC; Link MJ; Markovic S; Brown PD
Expert Rev Anticancer Ther; 2008 May; 8(5):743-55. PubMed ID: 18471047
[TBL] [Abstract][Full Text] [Related]
13. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.
Patel KR; Lawson DH; Kudchadkar RR; Carthon BC; Oliver DE; Okwan-Duodu D; Ahmed R; Khan MK
Neuro Oncol; 2015 Oct; 17(10):1312-21. PubMed ID: 26014049
[TBL] [Abstract][Full Text] [Related]
14. Melanoma brain metastasis: overview of current management and emerging targeted therapies.
Fonkem E; Uhlmann EJ; Floyd SR; Mahadevan A; Kasper E; Eton O; Wong ET
Expert Rev Neurother; 2012 Oct; 12(10):1207-15. PubMed ID: 23082737
[TBL] [Abstract][Full Text] [Related]
15. Pseudoprogression of Melanoma Brain Metastases.
Simard JL; Smith M; Chandra S
Curr Oncol Rep; 2018 Nov; 20(11):91. PubMed ID: 30413981
[TBL] [Abstract][Full Text] [Related]
16. A Case of Vanishing Brain Metastasis in a Melanoma Patient on Nivolumab.
Basnet A; Saad N; Benjamin S
Anticancer Res; 2016 Sep; 36(9):4795-8. PubMed ID: 27630330
[TBL] [Abstract][Full Text] [Related]
17. Metastatic melanoma to the brain: surgery and radiation is still the standard of care.
Nicholas S; Mathios D; Jackson C; Lim M
Curr Treat Options Oncol; 2013 Jun; 14(2):264-79. PubMed ID: 23504304
[TBL] [Abstract][Full Text] [Related]
18. [Systemic treatment of melanoma brain metastases].
Le Rhun É; Mateus C; Mortier L; Dhermain F; Guillot B; Grob JJ; Lebbe C; Thomas M; Jouary T; Leccia MT; Robert C
Cancer Radiother; 2015 Feb; 19(1):48-54. PubMed ID: 25656856
[TBL] [Abstract][Full Text] [Related]
19. Checkpoint inhibitors in the treatment of brain metastases of non-small-cell lung cancer and melanoma.
Kourie HR; Kanaan H; Awada G; Awada AH
Future Oncol; 2017 May; 13(12):1097-1103. PubMed ID: 28326837
[TBL] [Abstract][Full Text] [Related]
20. [Not Available].
Pagès C; Baroudjian B; Lebbé C
Bull Cancer; 2016 Nov; 103 Suppl 1():S132-S137. PubMed ID: 28057176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
